Getinge (GETI) Q2 2007 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2007 earnings summary
27 Oct, 2026Executive summary
Q2 orders received rose 25.3% to SEK 4,203m and net sales increased 28.0% to SEK 4,029m; organic growth was 5.1% for orders and 6.6% for sales.
Q2 EBITA before restructuring and integration costs increased 40.9% to SEK 603m; excluding these costs, the EBITA margin rose 1.4 percentage points to 15.0%.
Huntleigh integration was proceeding as planned; the 2007 earnings outlook remained favourable, with adjusted EBITA margin expected to improve including Huntleigh.
Financial highlights
Q2 gross profit was SEK 1,823m, up 28.2%; gross margin was 45.2%, unchanged YoY.
Q2 operating profit was SEK 496m, up 18.7%; profit before tax was SEK 366m, up 0.5%, and net profit was SEK 260m, down 2.3%.
H1 net sales rose 21.6% to SEK 7,444m; profit before tax increased 4.2% to SEK 652m and net profit rose 1.3% to SEK 463m.
H1 earnings per share increased 2.2% to SEK 2.29; Q2 EPS was SEK 1.29, down 1.5% YoY.
Outlook and guidance
2007 earnings outlook remained favourable; demand was considered excellent across most regions and product areas, with the order backlog at a historically excellent level.
EBITA margin was expected to improve for the overall business including Huntleigh, excluding Huntleigh restructuring and integration costs.
Huntleigh was expected to contribute to 2007 pre-tax profit; SEK 250–260m of its integration and restructuring costs were expected to be charged in 2007.
Extended Care targeted 2009 EBITA margin of at least 19% and organic growth of 7%; Huntleigh cost synergies were expected to exceed SEK 300m annually by 2009/2010.
Latest events from Getinge
- A 15% annual growth ambition pairs acquisitions with organic growth and supply-chain gains.GETI
CMD 2006 presentation - Growth and margin ambitions center on international reach, supply-chain gains and Huntleigh integration.GETI
CMD 2007 presentation - Cash flow improved, but acquisition funding lifted net debt to MSEK 10,365.GETI
CMD 2008 presentation - Datascope deal adds cardiovascular scale, with earnings accretion expected by 2010.GETI
Acquisition presentation - EBITA rose 33.5% as margins strengthened; Huntleigh integration and the 2007 outlook remained on plan.GETI
Q1 2007 - Q3 adjusted EBITA rose 33% as strong orders offset Huntleigh integration costs.GETI
Q3 2007 - Sales grew 26.5%; Boston acquisition and margin targets set the next growth phase.GETI
Q4 2007 - FY08 earnings climbed as Q4 organic orders grew 5.1%; FY09 adjusted EBITA target is 18–19%.GETI
Q4 2008 - Sales rose, but recession restrained organic growth as Datascope reshaped results.GETI
Q1 2009